🔹 CEO & Co-founder at Skyona LLC | Revolutionizing Healthcare Solutions 🔹Driving transformative change at the forefront of healthcare innovation, I lead Skyona LLC as its CEO and co-founder, dedicated to business development within Pharmaceutical and Biotechnology in an ever-evolving landscape.My leadership journey is marked by strategic prowess and a relentless pursuit of excellence:🔹 CEO, Genitrix: Pioneered groundbreaking strategies in therapeutic cancer vaccines, positioning the company as a frontrunner in the fight against cancer.🔹 CBO, Spirogen (Acquired by AstraZeneca for $440M): Orchestrated strategic partnerships that propelled Spirogen's acquisition, exemplifying resilience and vision in a competitive market.🔹 VP, Business Development, Bioject: Led negotiations for game-changing agreements, catalyzing the adoption of innovative needle-free injection technologies and driving market penetration.🔹 Director/Head of Business Development, Guilford Pharmaceuticals (Acquired by MGI Pharma for $177.5M): Strategically positioned Gliadel as a leading brain cancer treatment, orchestrating successful re-acquisition negotiations and ensuring continued market dominance.🔹 Previous Experience: Navigated the dynamic landscape of GlaxoSmithKline, honing strategic acumen and fostering innovation across Europe as a Group Product Manager.With a passion for disruptive innovation and a proven track record of driving growth, I thrive on the challenge of redefining healthcare paradigms and delivering impactful solutions.Let's connect to explore synergies and pioneer the future of healthcare together.